Xencor, Inc. (XNCR)
NASDAQ: XNCR · Real-Time Price · USD
8.69
-2.03 (-18.94%)
May 6, 2025, 2:56 PM EDT - Market open

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Engineered Antibody Therapeutics
110.49M
Log In
Log In
Log In
Log In
Upgrade
Engineered Antibody Therapeutics Growth
-34.36%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
United States
110.49M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
-34.36%
Log In
Log In
Log In
Log In
Upgrade
Non-United States
-
Log In
Log In
Log In
Log In
Upgrade
Non-United States Growth
-
Log In
Log In
Log In
Log In
Upgrade